Micron Biomedical Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2M
- Investors
-
12
Micron Biomedical General Information
Description
Operator of a biopharmaceutical company intended to develop microneedle patches for influenza and polio vaccines. The company's microneedle technology provides enhanced protective and therapeutic effects, patient compliance and simplified administration, enabling researchers to offer conventional vaccine delivery.
Contact Information
Website
www.micronbiomedical.comCorporate Office
- 311 Ferst Drive NorthWest
- Suite L1309
- Atlanta, GA 30332
- United States
Corporate Office
- 311 Ferst Drive NorthWest
- Suite L1309
- Atlanta, GA 30332
- United States
Micron Biomedical Timeline
Micron Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Grant | 14-Jan-2025 | $2M | Completed | Clinical Trials - Phase 1 | ||
| 10. Grant | 09-Jan-2025 | Completed | Clinical Trials - Phase 1 | |||
| 9. Later Stage VC (Series A3) | 26-Dec-2024 | Completed | Clinical Trials - Phase 1 | |||
| 8. Grant | 16-Nov-2023 | Completed | Clinical Trials - Phase 1 | |||
| 7. Later Stage VC (Series A) | 17-Apr-2023 | Completed | Clinical Trials - Phase 1 | |||
| 6. Later Stage VC (Series A) | 25-Nov-2022 | Completed | Clinical Trials - Phase 1 | |||
| 5. Grant | Completed | Clinical Trials - Phase 1 | ||||
| 4. Grant | 01-Sep-2020 | Completed | Clinical Trials - Phase 1 | |||
| 3. Grant | 01-Jan-2016 | $150K | Completed | Clinical Trials - Phase 1 | ||
| 2. Grant | 24-Feb-2015 | Completed | Clinical Trials - Phase 1 |
Micron Biomedical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-3 | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 45,800 | $0.000100 | 6% | $4.68 | $4.68 | 1x | $4.68 | 0.49% |
| Series A | 2,357,294 | $0.000100 | 6% | $5.85 | $5.85 | 1x | $5.85 | 25.48% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Micron Biomedical Comparisons
Industry
Financing
Details
Micron Biomedical Competitors (8)
One of Micron Biomedical’s 8 competitors is Altesa BioSciences, a Venture Capital-Backed company based in College Park, GA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Altesa BioSciences | Venture Capital-Backed | College Park, GA | ||||
| Medherant | Venture Capital-Backed | Coventry, United Kingdom | ||||
| GeoVax Labs | Corporation | Smyrna, GA | ||||
| Aruna Bio | Venture Capital-Backed | Athens, GA | ||||
| Arcturus Therapeutics Holdings | Formerly VC-backed | San Diego, CA |
Micron Biomedical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Micron Biomedical Patents
Micron Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260027041-A1 | Formulations and methods for a glp-1 agonist microneedle patch | Pending | 29-Jul-2024 | ||
| WO-2026030392-A1 | Formulations and methods for a glp-1 agonist microneedle patch | Pending | 29-Jul-2024 | ||
| US-20250325286-A1 | Methods and microneedle devices for vaccinations with enhanced delivery and acceptance | Pending | 17-Apr-2024 | ||
| WO-2025222045-A1 | Microneedle devices for vaccinations with enhanced delivery and acceptance | Pending | 17-Apr-2024 | ||
| EP-4784099-A1 | Solid compositions including stabilized lipid nanoparticles and methods of making microneedles comprising same | Pending | 26-Sep-2023 | A61K9/0021 |
Micron Biomedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Micron Biomedical Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BARDA | Government | |||
| J2 Ventures | Venture Capital | Minority | ||
| Devex Tecnologia e Sistemas | Corporation | Minority | ||
| Georgia Research Alliance | Not-For-Profit Venture Capital | Minority | ||
| Global Health Investment Corporation | Venture Capital | Minority |
Micron Biomedical FAQs
-
When was Micron Biomedical founded?
Micron Biomedical was founded in 2009.
-
Where is Micron Biomedical headquartered?
Micron Biomedical is headquartered in Atlanta, GA.
-
What is the size of Micron Biomedical?
Micron Biomedical has 25 total employees.
-
What industry is Micron Biomedical in?
Micron Biomedical’s primary industry is Drug Discovery.
-
Is Micron Biomedical a private or public company?
Micron Biomedical is a Private company.
-
What is Micron Biomedical’s current revenue?
The current revenue for Micron Biomedical is .
-
How much funding has Micron Biomedical raised over time?
Micron Biomedical has raised $32M.
-
Who are Micron Biomedical’s investors?
BARDA, J2 Ventures, Devex Tecnologia e Sistemas, Georgia Research Alliance, and Global Health Investment Corporation are 5 of 12 investors who have invested in Micron Biomedical.
-
Who are Micron Biomedical’s competitors?
Altesa BioSciences, Medherant, GeoVax Labs, Aruna Bio, and Arcturus Therapeutics Holdings are some of the 8 competitors of Micron Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
